Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing for neuroprotection in cerebrovascular surgery
ChiCTR-IID-17011576Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in cerebrovascular disease (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Plasma S-100β concentration, Plasma neuron-specific enolase (NSE) concentration and 1 more. Started Jul 2017; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cerebrovascular disease
Beyond the preview
Go deeper on ChiCTR-IID-17011576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IID-17011576.